RNA-Seq provides cost-effective alternative for typing self-identifying antigens in immunotherapy patients

The excitement surrounding immunotherapy is being driven by results in the clinic. Currently, autoimmunity is an unfortunate side-effect for a large fraction of those treated. Consequently, understanding how self-antigens are recognized is as important as characterizing the immune repertoire for efficacious delivery of these promising new therapies. Download this scientific poster presented at AACR 2016 Annual Meeting and learn how to measuring the tumor immune environment with RNA-Seq assays. 

Authors: Kimberly Robasky, Jason Powers, Donald Trapolsi, Jeff Jasper, Chad Brown, Victor Weigman

Complete the form below to access this scientific poster